BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 27589565)

  • 21. Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma.
    Iqbal J; Wright G; Wang C; Rosenwald A; Gascoyne RD; Weisenburger DD; Greiner TC; Smith L; Guo S; Wilcox RA; Teh BT; Lim ST; Tan SY; Rimsza LM; Jaffe ES; Campo E; Martinez A; Delabie J; Braziel RM; Cook JR; Tubbs RR; Ott G; Geissinger E; Gaulard P; Piccaluga PP; Pileri SA; Au WY; Nakamura S; Seto M; Berger F; de Leval L; Connors JM; Armitage J; Vose J; Chan WC; Staudt LM;
    Blood; 2014 May; 123(19):2915-23. PubMed ID: 24632715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A preclinical model of peripheral T-cell lymphoma GATA3 reveals DNA damage response pathway vulnerability.
    Kuczynski EA; Morlino G; Peter A; Coenen-Stass AML; Moss JI; Wali N; Delpuech O; Reddy A; Solanki A; Sinclair C; Calado DP; Carnevalli LS
    EMBO Mol Med; 2022 Jun; 14(6):e15816. PubMed ID: 35510955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival of Subcutaneous Panniculitis-Like T-Cell Lymphoma and Peripheral T-Cell Lymphoma Not Otherwise Specified: A Propensity-Matched Analysis of the Surveillance, Epidemiology, and End Results Database.
    Bhatt VR; Giri S; Verma V; Manandhar S; Pathak R; Bociek RG; Vose JM; Armitage JO
    Clin Lymphoma Myeloma Leuk; 2016 Jul; 16(7):373-8. PubMed ID: 27349764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The association of nm23-H1 expression with a poor prognosis in patients with peripheral T-cell lymphoma, not otherwise specified.
    Niitsu N
    J Clin Exp Hematop; 2014; 54(3):171-7. PubMed ID: 25501107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Analysis of Clinical Characteristics and Prognosis of 46 Elderly Patients with Peripheral T Cell Lymphoma (PTCL)].
    Wang TT; Zhang ZG; Yang HL; Li Q; Xia B; Zhao HF; Yu Y; Wang XF; Wang YF; Zhang YZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):438-43. PubMed ID: 27151006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Negative association between GATA3 and fascin could predict relapse-free and overall survival in patients with breast cancer.
    Min KW; Kim DH; Do SI; Chae SW; Kim K; Sohn JH; Pyo JS; Lee HJ; Kim DH; Oh S; Choi SH; Park YL; Park CH; Kim EK; Kwon MJ; Seo J; Moon KM
    Virchows Arch; 2016 Apr; 468(4):409-16. PubMed ID: 26719157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical significance of activated p-AKT expression in peripheral T-cell lymphoma.
    Hong JY; Hong ME; Choi MK; Chang W; Do IG; Jo JS; Jung SH; Park S; Kim SJ; Ko YH; Kim WS
    Anticancer Res; 2015 Apr; 35(4):2465-74. PubMed ID: 25862915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma.
    Heavican TB; Bouska A; Yu J; Lone W; Amador C; Gong Q; Zhang W; Li Y; Dave BJ; Nairismägi ML; Greiner TC; Vose J; Weisenburger DD; Lachel C; Wang C; Fu K; Stevens JM; Lim ST; Ong CK; Gascoyne RD; Missiaglia E; Lemonnier F; Haioun C; Hartmann S; Pedersen MB; Laginestra MA; Wilcox RA; Teh BT; Yoshida N; Ohshima K; Seto M; Rosenwald A; Ott G; Campo E; Rimsza LM; Jaffe ES; Braziel RM; d'Amore F; Inghirami G; Bertoni F; de Leval L; Gaulard P; Staudt LM; McKeithan TW; Pileri S; Chan WC; Iqbal J
    Blood; 2019 Apr; 133(15):1664-1676. PubMed ID: 30782609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epstein-Barr virus-positive nodal peripheral T cell lymphomas: clinicopathologic and gene expression profiling study.
    Ha SY; Sung J; Ju H; Karube K; Kim SJ; Kim WS; Seto M; Ko YH
    Pathol Res Pract; 2013 Jul; 209(7):448-54. PubMed ID: 23735590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FilGAP, a Rac-specific Rho GTPase-activating protein, is a novel prognostic factor for follicular lymphoma.
    Nishi T; Takahashi H; Hashimura M; Yoshida T; Ohta Y; Saegusa M
    Cancer Med; 2015 Jun; 4(6):808-18. PubMed ID: 25641953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcomes of peripheral blood stem cell transplantation for 38 patients with peripheral T-cell lymphoma.
    Bo J; Zhao Y; Zhang S; Hua W; Wang S; Gao C; Wang Q; Li H; Yu L
    J Cancer Res Ther; 2016; 12(3):1189-1197. PubMed ID: 28054534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD30 Expression by B and T Cells: A Frequent Finding in Angioimmunoblastic T-Cell Lymphoma and Peripheral T-Cell Lymphoma-Not Otherwise Specified.
    Onaindia A; Martínez N; Montes-Moreno S; Almaraz C; Rodríguez-Pinilla SM; Cereceda L; Revert JB; Ortega C; Tardio A; González L; García S; Camacho FI; González-Vela C; Piris MA
    Am J Surg Pathol; 2016 Mar; 40(3):378-85. PubMed ID: 26574847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Clinicopathologic Study of Lennert Lymphoma and Possible Prognostic Factors: The Importance of Follicular Helper T-cell Markers and the Association With Angioimmunoblastic T-cell Lymphoma.
    Kurita D; Miyoshi H; Yoshida N; Sasaki Y; Kato S; Niino D; Sugita Y; Hatta Y; Takei M; Makishima M; Ohshima K
    Am J Surg Pathol; 2016 Sep; 40(9):1249-60. PubMed ID: 27428734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of stem cell transplantation on the natural course of peripheral T-cell lymphoma: a real-world experience.
    Rohlfing S; Dietrich S; Witzens-Harig M; Hegenbart U; Schönland S; Luft T; Ho AD; Dreger P
    Ann Hematol; 2018 Jul; 97(7):1241-1250. PubMed ID: 29549411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01.
    d'Amore F; Relander T; Lauritzsen GF; Jantunen E; Hagberg H; Anderson H; Holte H; Österborg A; Merup M; Brown P; Kuittinen O; Erlanson M; Østenstad B; Fagerli UM; Gadeberg OV; Sundström C; Delabie J; Ralfkiaer E; Vornanen M; Toldbod HE
    J Clin Oncol; 2012 Sep; 30(25):3093-9. PubMed ID: 22851556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The gene expression profile and cell of origin of canine peripheral T-cell lymphoma.
    Owens E; Harris L; Harris A; Yoshimoto J; Burnett R; Avery A
    BMC Cancer; 2024 Jan; 24(1):18. PubMed ID: 38166662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of the histologic classification of peripheral T-cell lymphoma: a clinico-pathologic study of 71 HTLV-1 negative cases.
    Remotti D; Pescarmona E; Burgio VL; Gastaldi R; Guglielmi C; Martelli M; Mandelli F; Baroni CD
    Leuk Lymphoma; 1992 Nov; 8(4-5):371-9. PubMed ID: 1290962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative analysis of extra-nodal NK/T-cell lymphoma and peripheral T-cell lymphoma: significant differences in clinical characteristics and prognosis.
    Lim ST; Hee SW; Quek R; Lim LC; Yap SP; Loong EL; Sng I; Tan LH; Ang MK; Ngeow J; Tham CK; Ngo L; Tan MH; Tao M
    Eur J Haematol; 2008 Jan; 80(1):55-60. PubMed ID: 18028433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cutaneous peripheral T-cell lymphoma, not otherwise specified: A single-center prognostic analysis.
    Tolkachjov SN; Weenig RH; Comfere NI
    J Am Acad Dermatol; 2016 Nov; 75(5):992-999. PubMed ID: 27498959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical relevance of immunophenotype in a retrospective comparative study of 297 peripheral T-cell lymphomas, unspecified, and 496 diffuse large B-cell lymphomas: experience of the Intergruppo Italiano Linformi.
    Morabito F; Gallamini A; Stelitano C; Callea V; Guglielmi C; Neri S; Lazzaro A; Orsucci L; Ilariucci F; Sacchi S; Vitolo U; Federico M
    Cancer; 2004 Oct; 101(7):1601-8. PubMed ID: 15378507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.